Login / Signup

A Double-Blind, Randomized Controlled 12-Week Follow-Up Trial to Evaluate the Efficacy and Safety of Polycan in Combination with Glucosamine for the Treatment of Knee Osteoarthritis.

Thi Thanh Thuy TruongJong Min LimHyung-Rae ChoYoung Suk KimDuc Giang DaoQuoc Hung TranJae-Suk Choi
Published in: Evidence-based complementary and alternative medicine : eCAM (2019)
Among patients with mild or moderate osteoarthritis, a daily oral dose of Polycan (50 mg) in combination with glucosamine (750 mg or 1500 mg; Group A or B, respectively) resulted in a better treatment outcome than treatment with glucosamine (1500 mg) alone.
Keyphrases
  • knee osteoarthritis
  • phase iii
  • clinical trial
  • rheumatoid arthritis
  • phase ii
  • double blind
  • open label
  • randomized controlled trial
  • study protocol
  • combination therapy
  • high intensity